These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36691569)

  • 21. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
    PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging.
    Palaniyappan N; Cox E; Bradley C; Scott R; Austin A; O'Neill R; Ramjas G; Travis S; White H; Singh R; Thurley P; Guha IN; Francis S; Aithal GP
    J Hepatol; 2016 Dec; 65(6):1131-1139. PubMed ID: 27475617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenic T
    Hectors SJ; Bane O; Stocker D; Carbonell G; Lewis S; Kennedy P; Schiano TD; Thung S; Fischman A; Taouli B
    J Magn Reson Imaging; 2020 Sep; 52(3):787-794. PubMed ID: 32073207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Sartoris R; Rautou PE; Elkrief L; Pollorsi G; Durand F; Valla D; Spahr L; Terraz S; Soubrane O; Cauchy F; Vilgrain V; Ronot M
    Radiology; 2018 Dec; 289(3):698-707. PubMed ID: 30179109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.
    Llop E; Berzigotti A; Reig M; Erice E; Reverter E; Seijo S; Abraldes JG; Bruix J; Bosch J; García-Pagan JC
    J Hepatol; 2012 Jan; 56(1):103-8. PubMed ID: 21827733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
    Lens S; Baiges A; Alvarado-Tapias E; LLop E; Martinez J; Fortea JI; Ibáñez-Samaniego L; Mariño Z; Rodríguez-Tajes S; Gallego A; Bañares R; Puente Á; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; García-Pagán JC; Forns X
    J Hepatol; 2020 Dec; 73(6):1415-1424. PubMed ID: 32535060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal hypertension in hepatitis B-related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2-D shear-wave elastography.
    Zhu YL; Ding H; Fu TT; Peng SY; Chen SY; Luo JJ; Wang WP
    Hepatol Res; 2019 May; 49(5):540-549. PubMed ID: 30597744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis.
    Kumar A; Maruyama H; Arora A; Sharma P; Anikhindi SA; Bansal N; Kumar M; Ranjan P; Sachdeva M; Khare S
    J Med Ultrason (2001); 2022 Jul; 49(3):333-346. PubMed ID: 35876975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X
    Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis.
    Wang P; Hu X; Xie F
    PeerJ; 2023; 11():e15956. PubMed ID: 37727690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
    Paternostro R; Kwanten WJ; Hofer BS; Semmler G; Bagdadi A; Luzko I; Hernández-Gea V; Graupera I; García-Pagán JC; Saltini D; Indulti F; Schepis F; Moga L; Rautou PE; Llop E; Téllez L; Albillos A; Fortea JI; Puente A; Tosetti G; Primignani M; Zipprich A; Vuille-Lessard E; Berzigotti A; Taru MG; Taru V; Procopet B; Jansen C; Praktiknjo M; Gu W; Trebicka J; Ibanez-Samaniego L; Bañares R; Rivera-Esteban J; Pericas JM; Genesca J; Alvarado E; Villanueva C; Larrue H; Bureau C; Laleman W; Ardevol A; Masnou H; Vanwolleghem T; Trauner M; Mandorfer M; Francque S; Reiberger T;
    J Hepatol; 2024 May; ():. PubMed ID: 38823501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.
    Procopet B; Berzigotti A; Abraldes JG; Turon F; Hernandez-Gea V; García-Pagán JC; Bosch J
    J Hepatol; 2015 May; 62(5):1068-75. PubMed ID: 25514554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study.
    Jansen C; Bogs C; Verlinden W; Thiele M; Möller P; Görtzen J; Lehmann J; Vanwolleghem T; Vonghia L; Praktiknjo M; Chang J; Krag A; Strassburg CP; Francque S; Trebicka J
    Liver Int; 2017 Mar; 37(3):396-405. PubMed ID: 27569696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis.
    Liu S; Ma J; Chen P; Liu S; Guo Y; Tan M; Guo X; Feng Y; Wang Q; Li W; Yang C; Gao B; Hua Y; Liu N; Song H; He R; Wang R; Gao Q; Liu C; Qi X
    J Med Virol; 2024 Jan; 96(1):e29380. PubMed ID: 38235849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
    Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
    Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?
    Dajti E; Alemanni LV; Marasco G; Montagnani M; Azzaroli F
    Hepat Med; 2021; 13():25-36. PubMed ID: 33776492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
    De Vos N; Sartoris R; Cauchy F; Rautou PE; Vilgrain V; Ronot M
    Abdom Radiol (NY); 2020 Feb; 45(2):365-372. PubMed ID: 31797023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients.
    Kim TY; Jeong WK; Sohn JH; Kim J; Kim MY; Kim Y
    Liver Int; 2015 Nov; 35(11):2416-24. PubMed ID: 25875718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen.
    Hectors SJ; Bane O; Kennedy P; Cuevas J; Thung S; Fischman A; Friedman SL; Schiano TD; Taouli B
    Eur Radiol; 2021 Jul; 31(7):4804-4812. PubMed ID: 33411050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    Cho EJ; Kim MY; Lee JH; Lee IY; Lim YL; Choi DH; Kim YJ; Yoon JH; Baik SK
    PLoS One; 2015; 10(7):e0133935. PubMed ID: 26196942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.